Boehringer Ingelheim
Tracked across 12 events · 76 articles · First seen Dec 19, 2025 · Last active Jun 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Impact: Boehringer Ingelheim is expanding its global Computational Innovation footprint with a new AI and machine learning center in London, investing £150 million over 10 years to advance pharmaceutical R&D.
Apr 20, 2026 · 6 articles
Business
Impact: Boehringer Ingelheim entered into a global licensing agreement with Immunitas Therapeutics for a preclinical antibody program, strengthening its immunology pipeline and expanding its portfolio in autoimmune and inflammatory diseases.
May 12, 2026 · 6 articles
Business
Impact: Boehringer Ingelheim has entered into a partnership with Sequent Scientific — Alivira Animal Health Limited to expand its sales capabilities and market reach for companion animal products in India.
Jan 22, 2026 · 6 articles
Business
Impact: Boehringer Ingelheim India Private Limited signed an MoU with NIPER Hajipur to advance pharmaceutical research and education, providing access to its opnMe® platform and strengthening its commitment to India's pharmaceutical education network.
Apr 23, 2026 · 6 articles
Tech
Impact: Boehringer Ingelheim is collaborating with Suzhou Ribo Life Science Company on the MASH siRNA program, which has reached a significant milestone, advancing its pipeline for liver disease treatments.
May 06, 2026 · 7 articles
Regulatory
The United States — Food and Drug Administration (FDA) has approved Guardant360 CDx, a liquid biopsy test developed by Guardant Health, as a companion diagnostic for Boehringer Ingelheim's HERNEXEOS (zongertinib tablets). HERNEXEOS is the first…
Impact: Boehringer Ingelheim's HERNEXEOS received FDA approval with Guardant360 CDx as its companion diagnostic, marking a significant step in bringing a new targeted therapy to market for HER2-mutant NSCLC patients.
Jun 11, 2026 · 7 articles
Business
Impact: Boehringer Ingelheim is advertising for kidney disease screening with celebrity endorsements, participating in the health and telehealth advertising trend.
Feb 04, 2026 · 6 articles
Tech
Impact: Boehringer Ingelheim provided support for the global awareness survey and the development of materials sharing its results.
May 05, 2026 · 7 articles
International
Impact: Boehringer Ingelheim managers are traveling with Friedrich Merz, indicating a focus on deepening cooperation in the pharmaceuticals sector with India.
Jan 11, 2026 · 6 articles
85
Boehringer Ingelheim received approvalFDA approves Guardant360...
NEWSDESK
Track Boehringer Ingelheim live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard